Skip to main content
. 2017 Sep 1;7(6):657–664. doi: 10.1016/j.apsb.2017.07.004

Table 1.

Inhibition kinetic parameters of icotinib and erlotinib against UGT1A1-mediated NCHN-4-O-glucuronidation in both recombinant human UGT1A1 and HLMs.

Enzyme source Icotinib
Erlotinib
IC50 (μmol/L) Ki (μmol/L) Inhibition type IC50 (μmol/L) Ki (μmol/L) Inhibition type
UGT1A1 8.76 ± 0.78 10.04 Noncompetitive 0.69 ± 0.02 1.72 Noncompetitive
HLM 5.15 ± 0.28 8.55 Noncompetitive 0.68 ± 0.01 1.23 Noncompetitive